文献速递中枢神经肿瘤放疗放疗物理与技术

微型束放射治疗后免疫系统反应作用的评估

Evaluation of the Role of the Immune System Response After Minibeam Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-08-17

研究在大鼠原位胶质母细胞瘤模型中比较单次30 Gy常规放疗与同等平均剂量微型束放疗(MBRT),免疫健全与免疫缺陷大鼠生存分析及照射后2天和7天免疫细胞变化显示,MBRT疗效依赖T细胞,可诱导较强的抗肿瘤免疫反应并避免常规高剂量放疗的高毒性。

要点

  • 免疫缺陷Nude大鼠对MBRT无反应,提示T细胞是MBRT作用机制的关键。
  • 照射后1周MBRT组血液呈现炎症表型,与常规照射相比不同。
  • MBRT诱导CD8和CD4 T细胞更快招募,治愈动物再植入肿瘤细胞后无肿瘤生长。

核心结论

  • MBRT可在胶质母细胞瘤中激发较强的抗肿瘤免疫反应,同时避免常规高剂量放疗的高毒性。

研究设计与样本

  • 大鼠原位胶质母细胞瘤模型,单次30 Gy常规放疗或同等平均剂量单次MBRT。
  • 免疫健全F344大鼠与免疫缺陷Nude大鼠用于生存研究。
  • 照射后2天和7天用流式细胞术与免疫组化分析全身及瘤内免疫细胞群体变化。

主要发现

  • Nude大鼠对MBRT无反应,提示T细胞在MBRT作用机制中起关键作用。
  • 照射后1周MBRT组血液呈现炎症表型,与常规照射相比不同。
  • 流式细胞术显示常规放疗与MBRT组肿瘤内均有大量淋巴细胞浸润,特别是CD8 T细胞和B细胞。
  • 免疫组化显示MBRT诱导CD8和CD4 T细胞更快招募。
  • 被放疗治愈的动物再植入肿瘤细胞后未出现肿瘤生长,证明高剂量放疗后产生长期免疫反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Minibeam radiation therapy (MBRT) is an innovative technique that uses a spatial dose modulation. The dose distribution consists of high doses (peaks) in the path of the minibeam and low doses (valleys). The underlying biological mechanism associated with MBRT efficacy remains currently unclear and thus we investigated the potential role of the immune system after treatment with MBRT. METHODS AND MATERIALS: Rats bearing an orthotopic glioblastoma cell line were treated with 1 fraction of high dose conventional radiation therapy (30 Gy) or 1 fraction of the same mean dose in MBRT. Both immunocompetent (F344) and immunodeficient (Nude) rats were analyzed in survival studies. Systemic and intratumoral immune cell population changes were studied with flow cytometry and immunohistochemistry (IHC) 2 and 7 days after the irradiation. RESULTS: The absence of response of Nude rats after MBRT suggested that T cells were key in the mode of action of MBRT. An inflammatory phenotype was observed in the blood 1 week after irradiation compared with conventional irradiation. Tumor immune cell analysis by flow cytometry showed a substantial infiltration of lymphocytes, specifically of CD8 T cells and B cells in both conventional and MBRT-treated animals. IHC revealed that MBRT induced a faster recruitment of CD8 and CD4 T cells. Animals that were cured by radiation therapy did not suffer tumor growth after reimplantation of tumoral cells, proving the long-term immunity response generated after a high dose of radiation. CONCLUSIONS: Our findings show that MBRT can elicit a robust antitumor immune response in glioblastoma while avoiding the high toxicity of a high dose of conventional radiation therapy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Bertho A, Iturri L, Brisebard E, et al. Evaluation of the Role of the Immune System Response After Minibeam Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022. PMID: 35985455. doi:10.1016/j.ijrobp.2022.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。